エピジェネティクス市場：製品、技術、手法、用途、エンドユーザー別-2025-2030年の世界予測

エピジェネティクス市場は、2023年に37億1,000万米ドルと評価され、2024年には41億米ドルに達すると予測され、CAGR 10.82％で成長し、2030年には76億3,000万米ドルに達すると予測されています。

エピジェネティクスは、DNA配列の変化を伴わない遺伝子機能の遺伝的変化の研究を含む急成長分野であり、発生、疾病の発現、環境要因への応答などの複雑な生物学的プロセスを理解する上で重要な役割を果たしています。エピジェネティクスの必要性は、がん、神経疾患、自己免疫疾患など様々な疾患の根底にあるメカニズムを解明し、標的治療アプローチや個別化医療を可能にする可能性にあります。その用途は、創薬、バイオマーカー開発、農業、環境調査など多岐にわたり、最終用途は主にヘルスケア、製薬、バイオテクノロジー業界です。市場成長の原動力は、次世代シーケンシングやCRISPRなどの技術の進歩、慢性疾患の有病率の増加、研究開発への投資の増加です。しかし、エピゲノム研究に関連する高コスト、倫理的懸念、データ解釈の複雑さが大きな課題となっています。潜在的な機会を生かすために、利害関係者はシーケンスコストの削減とデータ解析ツールの強化に注力すべきです。学術機関と業界関係者のコラボレーションは、新規エピジェネティックターゲットの同定と対応する治療法の開発におけるイノベーションを促進する可能性があります。現在、北米や欧州のような地域は確立されたヘルスケアシステムにより市場をリードしているが、アジア太平洋の新興市場はインフラの改善やヘルスケア支出の増加により、有利な機会をもたらしています。規制上のハードルや限られた償還の枠組みといった限界は、市場の急速な拡大を妨げる可能性があります。技術革新の余地は、診断ツールの改善、エピジェネティックバイオマーカーの開発、エピジェネティックマークを修正できる新規治療法にあります。企業は競争力を維持するために、戦略的パートナーシップ、テーラーメイドの製品提供、データ分析のための人工知能の活用に注力すべきです。全体として、エピジェネティクス市場のダイナミックな性質は、課題を克服し、成長の大きな可能性を活用するために、機敏な戦略と持続的なイノベーションを必要としています。

市場力学：急速に進化するエピジェネティクス市場の主要市場インサイトを公開

エピジェネティクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の慢性疾患および遺伝性疾患の有病率の大幅な増加
  • 創薬開発に対する政府の積極的な取り組みと投資
  • 個別化医薬品への志向の高まり
• 市場抑制要因
  • エピジェネティクス技術の開発コストの高さ
• 市場機会
  • エピジェネティクスの進歩に向けた継続的な研究開発活動
  • エピジェネティクスの非がん領域への応用拡大
• 市場の課題
  • エピジェネティクスの認知度不足と応用範囲の狭さ

ポーターの5つの力エピジェネティクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、エピジェネティクス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：エピジェネティクス市場における外部からの影響の把握

外部マクロ環境要因は、エピジェネティクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析エピジェネティクス市場における競合情勢の把握

エピジェネティクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスエピジェネティクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、エピジェネティクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患および遺伝性疾患の有病率が著しく増加している
    • 医薬品の発見と開発に対する政府の好ましい取り組みと投資
    • パーソナライズ医療への傾向の高まり
  • 抑制要因
    • エピジェネティクス技術の開発コストが高い
  • 機会
    • エピジェネティクスの発展に向けた継続的な研究開発活動
    • エピジェネティクスの非腫瘍学分野への応用拡大
  • 課題
    • エピジェネティクスの認識不足と適用の制限
• 市場セグメンテーション分析
  • 製品：エピジェネ調査用試薬およびキットの使用増加
  • 技術：ゲノムワイドメチル化プロファイリングのための次世代シーケンシングの採用拡大
  • 方法：X染色体不活性化におけるDNAメチル化の利用増加
  • 応用：腫瘍学におけるエピジェネティックツールの応用の増加
  • エンドユーザー：学術機関や調査機関からのエピジェネティックツールの需要の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 エピジェネティクス市場：製品別

• 酵素
  • DNA修飾酵素
  • タンパク質修飾酵素
• 楽器とアクセサリー
• 試薬とキット
  • 5-hmCおよび5-mC分析キット
  • 抗体
  • 亜硫酸水素塩変換キット
  • ChiP-seqキット
  • ヒストン
  • 全ゲノム増幅キット
• サービス
• ソフトウェア

第7章 エピジェネティクス市場：技術別

• 質量分析
• 次世代シーケンシング
• ポリメラーゼ連鎖反応と定量的ポリメラーゼ連鎖反応
• 超音波処理

第8章 エピジェネティクス市場方法別

• DNAメチル化
• ヒストンの修飾

第9章 エピジェネティクス市場：用途別

• 心血管疾患
• 発生生物学
• 免疫学
• 代謝性疾患
• 腫瘍学

第10章 エピジェネティクス市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 製薬・バイオテクノロジー企業

第11章 南北アメリカのエピジェネティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のエピジェネティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのエピジェネティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ゼニスとセンコラが提携し、ZEN-3694プログラムを加速
  • FOXO、DataRobotと提携してAIベースのエピジェネティックバイオマーカー調査を実施
  • Zymo調査とOpentronsが提携し、新しい無細胞DNA分離化学を自動化
  • MSUの生化学者が自閉症スペクトラム障害のエピジェネティック調査のためにNIHから280万米ドルの助成金を受領
  • アジレント、がん調査向け高性能NGSターゲットエンリッチメントワークフローの開発会社Avida Biomedの買収を発表
  • アストラゼネカはパイプラインを前進させ、AACRで免疫腫瘍学、ADC、細胞療法、エピジェネティクスの進歩を強調
  • バイオモーダルが遺伝学とエピジェネティクスソリューションをリリース
  • クロマ・メディシンがエピジェネティック編集に注力
  • イプセンがエピザイムを買収、腫瘍学のポートフォリオを拡大
  • ゼニスエピジェネティクス、国立がん研究所（NCI）が後援する複数の腫瘍臨床試験の開始を発表

企業一覧

• Diagenode S.A. by Hologic, Inc.
• STORM Therapeutics LTD
• Qiagen N.V.
• Integrated DNA Technologies, Inc. by Danaher Corporation
• Active Motif, Inc.
• Merck KGaA
• Novogene Co, Ltd.
• GenomeScan
• Thermo Fisher Scientific Inc.
• Abnova Corporation
• New England Biolabs, Inc.
• Epigenic Therapeutics
• Ipsen
• Twist Bioscience Corporation
• F. Hoffmann-La Roche Ltd.
• AstraZeneca PLC
• GenScript Biotech Corporation
• Exact Sciences Corporation
• FOXO Technologies Inc.
• Watchmaker Genomics, Inc.
• Chroma Medicine, Inc.
• Cambridge Epigenetix Ltd.
• Bristol-Myers Squibb Company
• EpiCypher, Inc.
• Omega Therapeutics, Inc.
• Promega Corporation
• Bioneer Corporation
• PerkinElmer, Inc.
• Gilead Sciences, Inc.
• Eurofins Scientific SE
• ProteoGenix SAS
• Abcam PLC
• BioCat GmbH by AddLife AB
• Creative Diagnostics
• EpiGentek Group Inc.
• Lonza Group Ltd.
• Zenith Epigenetics Ltd.
• Agilent Technologies, Inc.
• BPS Bioscience, Inc.
• Fios Genomics Ltd.
• Creative Biogene
• Sound Agriculture Company
• Takara Holdings Inc.
• Illumina, Inc.
• Elysium Health, Inc.
• Pacific Biosciences of California, Inc
• Cusabio Technology LLC
• Zymo Research Corporation
• Bayer AG
• Bio-Rad Laboratories, Inc.
• MorphoSys AG

LIST OF FIGURES

• FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
• FIGURE 2. EPIGENETICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EPIGENETICS MARKET DYNAMICS
• TABLE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 65. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 66. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 67. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 68. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 102. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 103. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 104. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 105. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 109. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 110. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 111. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 112. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 147. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 154. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 161. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 168. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 175. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 190. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 197. EGYPT EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. EGYPT EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 204. FINLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. FINLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 211. FRANCE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. FRANCE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 218. GERMANY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. GERMANY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 225. ISRAEL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. ISRAEL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. ITALY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. ITALY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 229. ITALY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 230. ITALY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 231. ITALY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 232. ITALY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. ITALY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 239. NETHERLANDS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. NETHERLANDS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 246. NIGERIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. NIGERIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 253. NORWAY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 254. NORWAY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 255. POLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. POLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 257. POLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 258. POLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 259. POLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 260. POLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 261. POLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 262. QATAR EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 263. QATAR EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 264. QATAR EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 265. QATAR EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 266. QATAR EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 267. QATAR EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. QATAR EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 274. RUSSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 275. RUSSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 281. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 288. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 289. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 295. SPAIN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 296. SPAIN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 302. SWEDEN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 303. SWEDEN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 309. SWITZERLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 310. SWITZERLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 315. TURKEY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 316. TURKEY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 317. TURKEY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 322. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 323. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 324. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 329. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
• TABLE 330. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 331. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 332. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 333. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023

The Epigenetics Market was valued at USD 3.71 billion in 2023, expected to reach USD 4.10 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 7.63 billion by 2030.

Epigenetics, a burgeoning field involving the study of heritable changes in gene function that do not involve alterations in the DNA sequence, plays a crucial role in understanding complex biological processes such as development, disease manifestation, and response to environmental factors. The necessity of epigenetics lies in its potential to unravel mechanisms underlying various diseases, including cancer, neurological disorders, and autoimmune diseases, thus enabling targeted therapeutic approaches and personalized medicine. Its applications span across drug discovery, biomarkers development, agriculture, and environmental studies, with end-use predominantly in healthcare, pharmaceutical, and biotech industries. Market growth is driven by advancements in technology such as next-generation sequencing and CRISPR, increasing prevalence of chronic diseases, and growing investment in R&D. However, high costs associated with epigenomic research, ethical concerns, and complexity in data interpretation pose significant challenges. To capitalize on potential opportunities, stakeholders should focus on reducing sequencing costs and enhancing data analysis tools. Collaborations between academic institutions and industry players could foster innovation in identifying novel epigenetic targets and developing corresponding therapies. Currently, regions like North America and Europe lead the market due to established healthcare systems, but emerging markets in Asia-Pacific present lucrative opportunities owing to improving infrastructure and increasing healthcare expenditure. Limitations such as regulatory hurdles and limited reimbursement frameworks may hinder rapid market expansion. The scope for innovation lies in improved diagnostic tools, development of epigenetic biomarkers, and novel therapies that can modify epigenetic marks. Businesses should focus on strategic partnerships, tailored product offerings, and leveraging artificial intelligence for data analysis to stay competitive. Overall, the dynamic nature of the epigenetics market demands agile strategies and sustained innovation to navigate the challenges and capitalize on the vast potential for growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Epigenetics Market

The Epigenetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Significant growth in the prevalence of chronic and genetic disorders worldwide
  • Favorable governmental initiatives and investments in drug discovery and development
  • Growing inclination toward personalized medicines
• Market Restraints
  • High cost of development of epigenetics technologies
• Market Opportunities
  • Ongoing research and development activities for the advancement of epigenetics
  • Expanding the application of epigenetics in non-oncology fields
• Market Challenges
  • Lack of awareness and limited application of epigenetics

Porter's Five Forces: A Strategic Tool for Navigating the Epigenetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Epigenetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Epigenetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Epigenetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Epigenetics Market

A detailed market share analysis in the Epigenetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Epigenetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Epigenetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Diagenode S.A. by Hologic, Inc., STORM Therapeutics LTD, Qiagen N.V., Integrated DNA Technologies, Inc. by Danaher Corporation, Active Motif, Inc., Merck KGaA, Novogene Co, Ltd., GenomeScan, Thermo Fisher Scientific Inc., Abnova Corporation, New England Biolabs, Inc., Epigenic Therapeutics, Ipsen, Twist Bioscience Corporation, F. Hoffmann-La Roche Ltd., AstraZeneca PLC, GenScript Biotech Corporation, Exact Sciences Corporation, FOXO Technologies Inc., Watchmaker Genomics, Inc., Chroma Medicine, Inc., Cambridge Epigenetix Ltd., Bristol-Myers Squibb Company, EpiCypher, Inc., Omega Therapeutics, Inc., Promega Corporation, Bioneer Corporation, PerkinElmer, Inc., Gilead Sciences, Inc., Eurofins Scientific SE, ProteoGenix SAS, Abcam PLC, BioCat GmbH by AddLife AB, Creative Diagnostics, EpiGentek Group Inc., Lonza Group Ltd., Zenith Epigenetics Ltd., Agilent Technologies, Inc., BPS Bioscience, Inc., Fios Genomics Ltd., Creative Biogene, Sound Agriculture Company, Takara Holdings Inc., Illumina, Inc., Elysium Health, Inc., Pacific Biosciences of California, Inc, Cusabio Technology LLC, Zymo Research Corporation, Bayer AG, Bio-Rad Laboratories, Inc., and MorphoSys AG.

Market Segmentation & Coverage

This research report categorizes the Epigenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Enzymes, Instruments & Accessories, Reagents & Kits, Service, and Software. The Enzymes is further studied across DNA-Modifying Enzymes and Protein-Modifying Enzymes. The Reagents & Kits is further studied across 5-hmC & 5-mC Analysis Kit, Antibodies, Bisulfite Conversion Kits, ChiP-seq Kits, Histones, and Whole Genome Amplification Kits.
• Based on Technique, market is studied across Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction, and Sonication.
• Based on Methods, market is studied across DNA Methylation and Histone Modifications.
• Based on Application, market is studied across Cardiovascular Diseases, Developmental Biology, Immunology, Metabolic Diseases, and Oncology.
• Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant growth in the prevalence of chronic and genetic disorders worldwide
    • 5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
    • 5.1.1.3. Growing inclination toward personalized medicines
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development of epigenetics technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development activities for the advancement of epigenetics
    • 5.1.3.2. Expanding the application of epigenetics in non-oncology fields
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness and limited application of epigenetics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing usage of reagents & kits for epigenetic research
  • 5.2.2. Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
  • 5.2.3. Methods: Rising utilization of DNA methylation for X-chromosome inactivation
  • 5.2.4. Application: Increasing application of epigenetic tools in oncology
  • 5.2.5. End-User: Growing need for epigenetic tools from academic & research institutes
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Epigenetics Market, by Product

• 6.1. Introduction
• 6.2. Enzymes
  • 6.2.1. DNA-Modifying Enzymes
  • 6.2.2. Protein-Modifying Enzymes
• 6.3. Instruments & Accessories
• 6.4. Reagents & Kits
  • 6.4.1. 5-hmC & 5-mC Analysis Kit
  • 6.4.2. Antibodies
  • 6.4.3. Bisulfite Conversion Kits
  • 6.4.4. ChiP-seq Kits
  • 6.4.5. Histones
  • 6.4.6. Whole Genome Amplification Kits
• 6.5. Service
• 6.6. Software

7. Epigenetics Market, by Technique

• 7.1. Introduction
• 7.2. Mass Spectrometry
• 7.3. Next-Generation Sequencing
• 7.4. Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
• 7.5. Sonication

8. Epigenetics Market, by Methods

• 8.1. Introduction
• 8.2. DNA Methylation
• 8.3. Histone Modifications

9. Epigenetics Market, by Application

• 9.1. Introduction
• 9.2. Cardiovascular Diseases
• 9.3. Developmental Biology
• 9.4. Immunology
• 9.5. Metabolic Diseases
• 9.6. Oncology

10. Epigenetics Market, by End User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Epigenetics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Epigenetics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Epigenetics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Zenith and Cencora Partner to Expedite ZEN-3694 Programme
  • 14.3.2. FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research
  • 14.3.3. Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
  • 14.3.4. MSU biochemist Receives USD 2.8 million NIH Grant For Epigenetic Research on Autism Spectrum Disorder
  • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
  • 14.3.6. AstraZeneca Advances its Pipeline and Highlights Progress in Immuno-Oncology, ADCs, Cell Therapy and Epigenetics At AACR
  • 14.3.7. Biomodal Releases Genetics And Epigenetics Solution
  • 14.3.8. Chroma Medicine Raises Stakes in Epigenetic Editing
  • 14.3.9. Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
  • 14.3.10. Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials

Companies Mentioned

• 1. Diagenode S.A. by Hologic, Inc.
• 2. STORM Therapeutics LTD
• 3. Qiagen N.V.
• 4. Integrated DNA Technologies, Inc. by Danaher Corporation
• 5. Active Motif, Inc.
• 6. Merck KGaA
• 7. Novogene Co, Ltd.
• 8. GenomeScan
• 9. Thermo Fisher Scientific Inc.
• 10. Abnova Corporation
• 11. New England Biolabs, Inc.
• 12. Epigenic Therapeutics
• 13. Ipsen
• 14. Twist Bioscience Corporation
• 15. F. Hoffmann-La Roche Ltd.
• 16. AstraZeneca PLC
• 17. GenScript Biotech Corporation
• 18. Exact Sciences Corporation
• 19. FOXO Technologies Inc.
• 20. Watchmaker Genomics, Inc.
• 21. Chroma Medicine, Inc.
• 22. Cambridge Epigenetix Ltd.
• 23. Bristol-Myers Squibb Company
• 24. EpiCypher, Inc.
• 25. Omega Therapeutics, Inc.
• 26. Promega Corporation
• 27. Bioneer Corporation
• 28. PerkinElmer, Inc.
• 29. Gilead Sciences, Inc.
• 30. Eurofins Scientific SE
• 31. ProteoGenix SAS
• 32. Abcam PLC
• 33. BioCat GmbH by AddLife AB
• 34. Creative Diagnostics
• 35. EpiGentek Group Inc.
• 36. Lonza Group Ltd.
• 37. Zenith Epigenetics Ltd.
• 38. Agilent Technologies, Inc.
• 39. BPS Bioscience, Inc.
• 40. Fios Genomics Ltd.
• 41. Creative Biogene
• 42. Sound Agriculture Company
• 43. Takara Holdings Inc.
• 44. Illumina, Inc.
• 45. Elysium Health, Inc.
• 46. Pacific Biosciences of California, Inc
• 47. Cusabio Technology LLC
• 48. Zymo Research Corporation
• 49. Bayer AG
• 50. Bio-Rad Laboratories, Inc.
• 51. MorphoSys AG